Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-07

Clinical Trial Update: Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating Platelet Rich Fibrin with 1% alendronate for chronic periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet Rich Fibrin+1% Alendronate

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis | Phase 2, Phase 3 | Status: COMPLETED